ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Tinosinenside A ameliorates Alzheimer's disease-related pathology in APP/PS1 mice, accompanied by reduced neuroinflammation and altered microglial phenotype-associated marker expression.

Jingjing Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.